US2002058930A1PendingUtilityA1
Near infra-red selective photothermolysis for ectatic vessels and method therefor
Priority: Dec 9, 1994Filed: Jan 13, 1998Published: May 16, 2002
Est. expiryDec 9, 2014(expired)· nominal 20-yr term from priority
Inventors:Horace W. Furumoto
A61N 2005/0659A61B 18/22A61B 2017/00132A61B 18/203A61B 2017/00747A61N 5/067A61B 2018/00452A61B 2018/00458
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Near-infrared selective photothermolysis for the treatment of ectatic blood vessels, for example, blood vessels of a portwine stain birthmark. This technique is especially applicable to deeper lying blood vessels in view of the better penetration of the near infrared light. Consequently, vessels are below a dermal/epidermal boundary can be reached. Near-infrared is defined as a range of approximately 700 to 1,200 nm. The optimal colors are near 760 or between 980 to 990 nm for most populations.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method for performing selective photothermolysis, comprising:
generating near-infrared laser light; and treating vascular targets with the laser light.
2 . A method as claimed in claim 1 , further comprising treating ectatic blood vessels of vascular lesions with the laser light.
3 . A method as claimed in claim 2 , further comprising treating ectatic blood vessels of a portwine stain birthmark.
4 . A method as claimed in claim 1 , further comprising generating the laser light with a pulse duration of greater than 0.2 milliseconds.
5 . A method as claimed in claim 1 , further comprising generating the laser light with a pulse duration within a range of 1 to 10 milliseconds.
6 . A method as claimed in claim 1 , comprising irradiating the targets with laser light having a wavelength within a range of approximately 700 to 1,200 nm.
7 . A method as claimed in claim 1 , wherein the laser light has a wavelength within a range of approximately 700 to 1000 nm.
8 . A method as claimed in claim 1 , wherein the laser light has a wavelength within a range of approximately 720-790 nm.
9 . A method as claimed in claim 1 , wherein the laser light has a wavelength within a range of approximately 750 to 780 nm.
10 . A method as claimed in claim 1 , wherein the laser light has a wavelength of approximately 760 nm.
11 . A method as claimed in claim 1 , further comprising generating the laser light with an alexandrite laser.
12 . A method as claimed in claim 1 , further comprising generating the laser light with a titanium sapphire laser.
13 . A method as claimed in claim 1 , further comprising generating the laser light with a chromium-doped fluoride laser.
14 . A method as claimed in claim 1 , further comprising generating the laser light with a semiconductor diode laser.
15 . A method as claimed in claim 1 , further comprising transmitting the laser light to the vascular target of a patient with an optical fiber delivery.
16 . A method as claimed in claim 1 , further comprising time multiplexing the output of at least one laser to generate the laser pulse.
17 . A near-infrared selective photothermolysis device for treatment of vascular lesions, the device comprising:
a laser system for generating near-infrared laser light pulses having durations greater than 0.2 milliseconds; and a delivery system for transmitting the laser light pulses to vascular targets of a patient.
18 . A device as claimed in claim 17 , wherein the vascular targets are ectatic blood vessels of a portwine stain birthmark.
19 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength in a range of approximately 700 to 1,200 nm.
20 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength in a range of approximately 700 to 1000 nm.
21 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength in a range of approximately 750 to 780 nm.
22 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength of approximately 760 nm.
23 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength in a range of approximately 800 to 1200 nm.
24 . A device as claimed in claim 17 , wherein the laser light pulses have a wavelength in a range of approximately 720-950 nm.
25 . A device as claimed in claim 17 , wherein the laser system comprises an Alexandrite laser.
26 . A device as claimed in claim 17 , wherein the laser system comprises a titanium sapphire laser.
27 . A device as claimed in claim 17 , wherein the laser system comprises a chromium doped fluoride laser.
28 . A device as claimed in claim 17 , wherein the laser system comprises a semi-conductor diode laser.
29 . A device as claimed in claim 17 , wherein the laser system multiplexes pulses from at least one laser to generate a longer effective pulse duration.
30 . A device as claimed in claim 17 , wherein the delivery system comprises an optical fiber for combining and delivering light from at least one laser.
31 . A device as claimed in claim 17 , wherein an effective pulse duration of the light pulse is between 1 and 10 msec.
32 . A method for treating a vascular lesion, the method comprising:
irradiating the lesion with near-infrared laser light pulses; and controlling a duration of the pulses to approximately match a thermal relaxation time of blood vessels of the targets.
33 . A method as claimed in claim 32 , further comprising generating the laser light pulses at a wavelength in a range of approximately 720 to 790 nm.Join the waitlist — get patent alerts
Track US2002058930A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.